- tylosin tartrate
-
- $0.00 / 25KG
-
2025-05-16
- CAS:74610-55-2
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
- Tylosin tartrate
-
- $0.00 / 25KG
-
2025-05-16
- CAS:74610-55-2
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
- Tylosin tartrate
-
- $0.00 / 25Kg/Drum
-
2025-05-16
- CAS:74610-55-2
- Min. Order: 25KG
- Purity: ≥900μ/mg; EP9.0
- Supply Ability: 20tons/month
|
| Tylosin tartrate Basic information |
| Tylosin tartrate Chemical Properties |
Melting point | 140-146 °C | storage temp. | Inert atmosphere,Store in freezer, under -20°C | solubility | H2O: 50 mg/mL, clear, yellow-green | form | powder | color | colorless to yellow | InChIKey | TYMALGUEUDCGQA-ULWJMSOTSA-N |
| Tylosin tartrate Usage And Synthesis |
Chemical Properties | Light yellow powder | Uses | Tylosin Tartrate is a macrolide antibiotic isolated from a strain of Streptomycetes fradiae found in soil from Thailand. Antibacterial. | Uses | Tylosin tartrate is used as chemotherapeutic agent used to treat pigs with enteritis, household pets with respiratory infections and mastitis in cows. | Uses | Tylosin tartrate is a macrolide antibiotic approved for the control of mycoplasmosis in poultry | in vivo | Tylosin tartrate (10-500 mg/kg; s.c.) generally suppresses the elevated TNF-α and IL-1β levels and increases the IL-10 levels in the Lipopolysaccharide (LPS) -treated animals[4].
Animal Model: | Balb/C mice (2-3 months old, 20-25 g)[4] | Dosage: | 10 mg/kg, 100 mg/kg, 500 mg/kg | Administration: | Subcutaneous injection | Result: | Reduced the elevated TNF-α and IL-1β in LPS (250 μg)-treated mice but increased their IL-10 levels. |
| IC 50 | Macrolide |
| Tylosin tartrate Preparation Products And Raw materials |
|